Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

Adam Raff appointed as Orbital Therapeutics’ Senior Vice President, Clinical Development

Raff will lead Clinical and Regulatory Operations and will be part of the company’s executive leadership team

- PMLiVE

Atlantic currents: the changing tide of health policy in the US and Europe

By Noah Froud

- PMLiVE

Why Trust Remains the Primary Driver of Pharma Success

In an age of precision medicine, AI-driven drug discovery, and blockbuster biologics, it’s tempting to assume clinical trial outcomes alone dictate success in pharma. But the reality is more nuanced:...

EatMoreFruit

- PMLiVE

PhotoPharmics’ new advisory board to guide launch of FDA Breakthrough device for Parkinson’s

The US-based company develops light-based therapies for neurodegenerative conditions

- PMLiVE

TRIMTECH Therapeutics establishes Scientific Advisory Board

Alessio Ciulli has been appointed as Chair of the board

- PMLiVE

Medscape Education Returns as Thought Leaders to AIS 2025

📍 September 8–10, 2025 Hilton at Penn’s Landing | Philadelphia, PA Medscape Education is proud to return to the 2025 Alliance Industry Summit (AIS) as a Silver Sponsor and leading...

Medscape Education

- PMLiVE

Genentech starts construction on manufacturing facility in North Carolina, US

The $700m project is part of Roche’s $50bn investment in the US

- PMLiVE

David Weinreich appointed as Merck’s Global Head of R&D and CMO, Healthcare

Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

- PMLiVE

Enhancing Medical Education through Gamification and Innovative Technologies

One innovative approach that has gained traction in recent years is gamification—the integration of game elements such as points, leaderboards, and interactive elements into learning activities. Understanding gamification’s role in...

Impetus Digital

- PMLiVE

UK’s first new type of antibiotic for UTIs in nearly 30 years approved by MHRA

The oral pill is effective against many drug-resistant infections, including E. coli

- PMLiVE

Zack Lentz appointed as Chief Commercial Officer at OPEN Health

Lentz’ previous roles include CGO at Inizio Medical and President & CSO at Vaniam Group

- PMLiVE

EMA orphan drug designation given to ReAlta for graft-versus-host disease therapy

This follows preliminary results from the company's ongoing phase 2 trial

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links